CAVINTON

This brand name is authorized in Ecuador, Estonia, Lithuania, Poland, Romania, Singapore

Active ingredients

The drug CAVINTON contains one active pharmaceutical ingredient (API):

1 Vinpocetine UNII 543512OBTC - VINPOCETINE

Read about Vinpocetine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06BX18	Vinpocetine	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BX Other psychostimulants and nootropics
Discover more medicines within N06BX18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 367520813
Country: EE	Ravimiamet	Identifier(s): 1088052
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002956, 1003646, 1004547, 1005104, 1005105, 1015313, 1058185, 1058186, 1058187, 1066905, 1067515, 1073942, 1078644, 1078645, 1079685, 1080183, 1081429, 1082391, 1087829, 1087830, 1087831, 1088488
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100013169, 100013175, 100120095, 100260212, 100263239, 100265706, 100265965, 100269503, 100292413, 100292650, 100294949, 100324290, 100349716, 100351676, 100393083, 100396740, 100398123, 100418794, 100424091, 100425417, 100426256, 100435901, 100437001
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W54827001, W54827002, W54828001
Country: SG	Health Sciences Authority	Identifier(s): 00396P